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According to the American Pain Society, pain is one of the most common
symptoms why patients search medical attention. A recent achievement in
pain research was the identification of Transient Receptor Potential (TRP)
channels as analgesic targets. The superfamily of TRP ion channels consists
of 28 different members in mammalians. The sensitivity of TRP channels to
a broad array of stimuli allows them to function as biological sensors involved
in processes ranging from vision to taste, and tactile sensation. The so-called
thermoTRPs (temperature sensitive) are typically expressed in sensory neu-
rons, where they act as primary thermosensors for the detection of innocuous
and noxious temperatures. Recently, our research group identified high
TRPM3 expression in nociceptor neurons, where it plays a decisive role in
the nocifensive response to pregnenolone sulphate (PS) and heat and in the
development of heat hyperalgesia during inflammation.
This project aims to validate TRPM3 as a potential target for the development
of new analgesics. Therefore, we purpose to identify new potent and selective
TRPM3 blockers, and show their ability to cure different pain conditions in
vivo.
In collaboration with the Center for Drug Design and Development (CD3) we
identified a new potent TRPM3 blocker (CIM056741) that showed a high selec-
tivity for TRPM3 compared to other related TRP channels. The blocker was
able to inhibit PS induced [Ca2þ]i signals in isolated DRG neurons. Further-
more, CIM056741 significantly reduced the sensitivity of mice and rats to
noxious heat and PS-induced chemical pain. Interestingly, injection of
CIM056741 strongly reduced the inflammatory induced mechanical hyperalge-
sia and was without effect on body core temperature, heart rate and locomotor
activity.
In conclusion, the obtained results validate TRPM3 as a potential target for new
analgesic treatments in humans.
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Transient receptor potential channel polycystin subfamily (TRPP) proteins
assemble with polycystic kidney disease (PKD) proteins to form functionally
important complexes. For example, the TRPP2/PKD1 receptor-ion channel
complex plays a critical role in renal physiology. Mutations in either protein
cause autosomal dominant polycystic kidney disease (ADPKD), one of the
most common genetic diseases in humans. A similar complex, assembled by
TRPP3 and PKD1L3, is a candidate for the sour taste receptor. The TRPP2/
PKD1 complex contains three TRPP2 subunits and one PKD1 subunit and
the interaction between their C-termini is crucial for the complex assembly.
The TRPP3/PKD1L3 complex has the same subunit stoichiometry but its
assembly involves interactions between the transmembrane segments of both
proteins. These interactions have been shown to be essential for the assembly,
surface expression and function of the complexes. Here we find another novel
binding site between these proteins. When co-expressed in HEK293T cells, the
extracellular loops between the first and second transmembrane segments (I-II
loop) of TRPP2 and TRPP3 associate with the extracellular loops between the
sixth and seventh transmembrane segments (VI-VII loop) of PKD1 and
PKD1L3 respectively. These loops can also associate with their binding part-
ners when the latter is expressed as full-length proteins. The loop-loop associ-
ations are functionally crucial since expression of either the TRPP3 I-II loop or
the PKD1L3 VI-VII loop shows dominate negative effect on the acid-induced
current of TRPP3/PKD1L3 complex. These results demonstrate, for the first
time, the previously unknown essential role that these extracellular loops
play in the assembly of TRPP/PKD complexes.
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Nicotinic acid (niacin or Vitamin B3) has been widely used in the last 50 years
to treat dyslipidemias and represents an effective and safe means to reduce therisk of mortality from cardiovascular disease. Nonetheless, a substantial frac-
tion of patients discontinue treatment due to a strong side effect of cutaneous
vasodilation, commonly termed flushing. As a multi-component complex bio-
logical event, the molecular mechanism of flushing is not completely under-
stood yet. In the present study, we tested the hypothesis that nicotinic acid
causes flushing by activating the capsaicin receptor TRPV1, a polymodal
cellular sensor that mediates a similar flushing response upon consumption
of spicy food.
Indeed, we observed that the nicotinic acid-induced increase in blood flow was
substantially reduced in Trpv1-/- knockout mice, indicating involvement of the
channel in flushing response. Using exogenously expressed TRPV1, we
confirmed that, at millimolar concentrations, nicotinic acid directly and
potently activates TRPV1 from the intracellular side, but very weakly activates
its homolog TRPV3 while inhibiting TRPV2 and TRPV4. Binding of nicotinic
acid to TRPV1 lowers its activation threshold for heat, causing channel opening
at physiological temperatures. Activation of TRPV1 by voltage or ligands
(capsaicin and 2-APB) is also potentiated by nicotinic acid. Furthermore, nico-
tinic acid does not compete directly with capsaicin but may activate TRPV1
through the 2-APB activation pathway. Using live-cell fluorescence imaging,
we observed that nicotinic acid can quickly enter the cell through a
transporter-mediated pathway to activate TRPV1. In conclusion, direct activa-
tion of TRPV1 by nicotinic acid may lead to a cutaneous vasodilatory response
that contributes to flushing, suggesting a potential novel pathway to inhibit
flushing and improve compliance.
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We measured free Mg2þ concentration ([Mg2þ]i) in rat ventricular myocytes
using a fluorescent indicator furaptra (mag-fura-2). [Mg2þ]i decreased from
~0.9 mM to 0.2-0.5 mM by incubation of the cells in a high-Kþ (Ca2þ-
and Mg2þ-free) solution, and recovered by perfusion with Ca2þ-free
Tyrode’s solution containing 1 mM Mg2þ. The time course of the [Mg2þ]i
recovery was fitted by a single exponential function, and the first derivative
at time 0 was analyzed as an initial Mg2þ influx rate. In order to characterize
physiological Mg2þ influx pathways, we used known TRPM7 inhibitors,
2-Aminoethoxydiphenyl borate (2-APB) and NS8593. The initial rate of
Mg2þ influx was decreased to 43510 % (n=6) by 100 mM 2-APB, and to
1258.6 % (n=5) by 10 mM NS8593. These compounds inhibited the Mg2þ
influx with half inhibitory concentrations (IC50) of 17 mM (2-APB) and 2.0
mM (NS8593). 2-APB and NS8593 also inhibited Ni2þ influx when estimated
by quenching of furaptra fluorescence with IC50 values of, respectively, 20
mM and 4.4 mM; these values are comparable to those for Mg2þ influx. Under
the whole-cell patch-clamp configuration, removal of intracellular and extra-
cellular divalent cations induced large inward and outward currents, IMIC,
carried by monovalent cations likely via TRPM7 channels. The IMIC
measured at 120 mV was diminished to 4853.6 % (n=7) by 100 mM
2-APB, and to 50512 % (n=4) by 10 mM NS8593. These results support
our previous conclusion [Biophys J 102:664a, 2012] that TRPM7/MIC chan-
nels serve as a major physiological pathway of Mg2þ influx in rat ventricular
myocytes.
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Several members of the transient receptor potential cation (TRPC) channel
family are stretch activated. They are thought to play a critical role in
mechano-electrical coupling in cardiac myocytes and in cardiac hypertrophic
remodeling. However, studies on their subcellular localization in cardiomyo-
cytes are conflicting, and their functions in cardiac myocytes are barely
understood. In this study, we investigated the spatial distribution of TRPC
channels in isolated ventricular myocytes from adult rabbit using immunolab-
eling and three-dimensional confocal microscopy. Colocalization of TRPC
with (i) sarcolemma labeled with wheat germ agglutinin (WGA), (ii) sarco-
plasmic reticulum (SR) labeled for SR calcium ATPase (SERCA2), and
(iii) cytoskeletal proteins including sarcomeric a-actinin, desmin, vinculin
and b-tubulin, was assessed by a quantitative approach. Furthermore, we
measured stretch-activated current with whole-cell voltage clamping. Our
results from confocal imaging revealed a transverse striated distribution of
TRPC1 and TRPC6 channels. We found colocalization of TRPC1 and
TRPC6 with sarcomeric a-actinin, SERCA2A and desmin, but not with
